AlzChem Group

Widely held, no controlling shareholder — free float 73.48% per AlzChem's own IR disclosure. No named holder approaches a blocking/majority stake; legacy majority shareholders (LIVIA Corporate Development SE, HDI Vier CE GmbH, Edelweiss Holding GmbH) sold down via a secondary offering, raising free float from ~26% (historic, pre-offering) to ~75%. GLEIF (LEI 8945004EL7WZK3ERG181) reports no parent on file, consistent with a widely-held listed entity.

Every exposure is read as a buyer dependency by model default, not a company disclosure; the top 1 are its binding chokepoints. If this company actually produces one of these materials rather than buying it, that would be misclassified here — no producer-classifier entry exists for any of them.

As a buyer, policy pressure across its consumed materials is rising.

Descriptive trend in official policy actions on this company’s materials — a policy-pressure trend, not a price or trading signal. No forward probability is implied. Direction is measured on actions we have discovered, and discovery lags events: where the recent window is too thin to support a calm reading, the row says coverage-limited instead of easing.

No actions in the register have named or swept this company in the last 24 months.